← Eichor
Condition: Sodium Glucose Cotransporter 2 Inhibitor Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Sodium Glucose Cotransporter 2 Inhibitor

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Effects of Continued Administration of Empagliflozin in Patients With Heart Failure on Active SGLT2 Inhibitor Treatment
Phase 3 · 9 location(s) · Christian Schulze · NCT07038356Impact of SGLT2 Inhibitors on Chronic Peritoneal Dialysis Patients.
NA · 1 location(s) · Oman Ministry of Health · NCT07491042Safety and Efficacy of Canagliflozin in Patients With Metastatic High Microsatellite Instability (MSI-H) Colorectal Canc
Phase 1 · 1 location(s) · West China Hospital · NCT07076823Sodium-Glucose Cotransporter 2 Inhibitors for Repaired Tetralogy of Fallot Patients for Enhancement of Cardio-Pulmonary
Phase 4 · 1 location(s) · The University of Hong Kong · NCT06668389SGLT2i, Pioglitazone, and Ketone Production in T1D
Phase 3 · 1 location(s) · The University of Texas Health Science Center at San Antonio · NCT07056699Randomized Clinical Trial to Evaluate the Effect of Dapagliflozin in Patients With Diabetic Macular Edema
Phase 2 · 1 location(s) · Alexandria University · NCT06845163The Effect of Dapagliflozin on Exercise and Cardiac Functional Status of Patients After Fontan Procedure
Phase 4 · 2 location(s) · The University of Hong Kong · NCT07482943Strategic Lifestyle Intervention for Metabolic Syndrome (SLIM-MET)
NA · 1 location(s) · National Health Research Institutes, Taiwan · NCT06271200Mechanism of SGLT2 Inhibition in the Kidney
Phase 4 · 1 location(s) · University of Michigan · NCT06291155Dapagliflozin and Endothelin Receptor Antagonism in Large Vessel Vasculitis (DERAIL-LVV)
Phase 2 · 1 location(s) · University of Edinburgh · NCT06887062SGLT2 Inhibitor TrEatment iN Patients Awaiting cOronary arTery bYpass Surgery to Reduce Post-opErative AF
Phase 3 · 8 location(s) · Region Örebro County · NCT05852704Effect of Empagliflozin on Metabolic Outcomes in Adults Living With HIV Receiving Dolutegravir-Based Therapy
Phase 2 · 1 location(s) · Abdelrahman Mahmoud · NCT07336797Peri-treatment of SGLT-2 Inhibitor on Myocardial Infarct Size and Remodeling Index in Patients With Acute Myocardial Inf
Phase 4 · 1 location(s) · Samsung Medical Center · NCT04899479Triple Combination Therapy (ARNI, SGLT2i, MRA) in Advanced HFpEF
Phase 2 · 1 location(s) · National Medical Research Center for Cardiology, Ministry of · NCT06655480SGLT2i Improve Left Atrial Function in Patients With Paroxysmal Atrial Fibrillation, Hypertension and Abnormal Glucose M
Phase 2 · 1 location(s) · Huashan Hospital · NCT07482020Adipose Dysfunction, Imaging, Physiology, and Outcomes With Sodium Glucose Cotransporter 2 Inhibitor (SGLT2i) for Sleep
Phase 4 · 2 location(s) · Yale University · NCT05612594Effect of Dapagliflozin on Right Ventricular-Pulmonary Artery Coupling After Off-Pump Coronary Atery Bypass Grafting
Phase N/A · 1 location(s) · Pyatigorsk City Clinical Hospital Number 1 · NCT07601867Effect at 3 Months of Early Empagliflozin Initiation in Cardiogenic Shock Patients on Mortality, Rehospitalization, Left
Phase 3 · 8 location(s) · Central Hospital, Nancy, France · NCT05879276The Efficacy and Safety of Sodium-glucose Cotransporter 2 Inhibitors in Patients With Acute Kidney Disease
Phase 2 · 1 location(s) · National Taiwan University Hospital · NCT06528405Improving Coronary Vascular Health in Women
Phase 2 · 1 location(s) · Massachusetts General Hospital · NCT06843902The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination
Phase N/A · 1 location(s) · University of Athens · NCT03878706Dapagliflozin in Active Lupus Nephritis
Phase 4 · 2 location(s) · Brigham and Women's Hospital · NCT07323524SGLT2 Inhibitors on Clinical Outcomes and Left Ventricular Remodeling in Type 2 Diabetic Patients with Acute Myocardial
Phase N/A · 1 location(s) · Kiyuk Chang · NCT05770687Enavogliflozin for the Management of Patients With Amyloid CardiomyopaThy
Phase 4 · 2 location(s) · Seoul St. Mary's Hospital · NCT07240844Effects of the SGLT2 Inhibitor Empagliflozin in Patients With Euvolemic and Hypervolemic Hyponatremia
Phase 4 · 6 location(s) · University Hospital, Basel, Switzerland · NCT04447911ENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement
Phase 4 · 31 location(s) · Duk-Woo Park, MD · NCT05672836DICE Study- Diastolic Improvement With Carvedilol & Empagliflozin in Patients With Cirrhosis
Phase 4 · 1 location(s) · Post Graduate Institute of Medical Education and Research, C · NCT07322237A Phase IV Clinical Trial to Compare the Efficacy and Safety of Metformin+Sodium-Glucose Cotransporter 2 Inhibitor(SGLT2
Phase 4 · 1 location(s) · Boryung Pharmaceutical Co., Ltd · NCT06972732Short-term Effects of an SGLT2 Inhibitor on Divalent Ions in Autosomal Dominant Polycystic Kidney Disease
Phase 2 · 2 location(s) · Cantonal Hospital Graubuenden · NCT06435858Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy
Phase 1 · 1 location(s) · Vanderbilt University Medical Center · NCT07172971
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.